Drug Shortage Report for TOBRAMYCIN INHALATION SOLUTION

Last updated on 2020-12-14 History
Report ID 129111
Drug Identification Number 02443368
Brand name TOBRAMYCIN INHALATION SOLUTION
Common or Proper name TOBRAMYCIN INHALATION SOLUTION
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TOBRAMYCIN
Strength(s) 300MG
Dosage form(s) SOLUTION
Route of administration INHALATION INHALATION
Packaging size 56 LIIN
ATC code J01GB
ATC description AMINOGLYCOSIDE ANTIBACTERIALS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2020-11-27
Estimated end date 2020-12-11
Actual end date 2020-12-11
Shortage status Resolved
Updated date 2020-12-14
Company comments
Health Canada comments
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-12-14 French Compare
v4 2020-12-14 English Compare
v3 2020-11-28 English Compare
v2 2020-11-27 French Compare
v1 2020-11-27 English Compare